ISIS PHARMACEUTICALS INC's ticker is and the CUSIP is 464330909. A total of 5 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,592,000 | +37.3% | 113,600 | +95.5% | 0.02% | +26.7% |
| Q2 2015 | $3,344,000 | -55.8% | 58,100 | -51.1% | 0.02% | -55.9% |
| Q1 2015 | $7,564,000 | +37.7% | 118,800 | +33.5% | 0.03% | +54.5% |
| Q4 2014 | $5,495,000 | +76.5% | 89,000 | +11.0% | 0.02% | +69.2% |
| Q3 2014 | $3,114,000 | +78.7% | 80,200 | +58.5% | 0.01% | +62.5% |
| Q2 2014 | $1,743,000 | -54.4% | 50,600 | -42.8% | 0.01% | -50.0% |
| Q1 2014 | $3,824,000 | +15.9% | 88,500 | +6.9% | 0.02% | +33.3% |
| Q4 2013 | $3,299,000 | -28.1% | 82,800 | -32.3% | 0.01% | -25.0% |
| Q3 2013 | $4,591,000 | +166.1% | 122,300 | +90.5% | 0.02% | +166.7% |
| Q2 2013 | $1,725,000 | – | 64,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|